Intrinsic Value of S&P & Nasdaq Contact Us

McKesson Corporation MCK NYSE

NYSE • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
65/100
3/7 Pass
SharesGrow Intrinsic Value
$1,623.29
+88.1%
Analyst Price Target
$982.38
+13.9%

McKesson Corporation (MCK) generated $6.09B in operating cash flow for fiscal year 2025. After capital expenditures of $0.00, free cash flow was $6.09B.

Free cash flow margin was 1.7% of revenue. Cash conversion ratio was 1.75x, indicating earnings are backed by cash.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (55/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (30/100) — Cash conversion ratio was 1.75x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 65/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
65/100
SG Score
View full scorecard →
~
VALUE
51/100
Price-to-Earnings & upside
→ Valuation
FUTURE
82/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
55/100
Proven by this page
GROWTH
90/100
→ Income
INCOME
30/100
→ Income
McKesson Corporation Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $10.48B$6.09B$4.31B$5.16B$4.43B
Capital Expenditure $-386M$0.00$-687M$-558M$-535M
Free Cash Flow $10.1B$6.09B$3.63B$4.6B$3.9B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message